Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
The outbreak of Covid-19 started several clinical trials and treatment experiments all over the world in the first months of 2020. This study investigates reports of adverse events related to used molecules, including but not limited to protease inhibitors (lopinavir/ritonavir), chloroquine, azithromycin, remdesivir and interferon beta-1a. Analyses of reports also include the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).
Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Renal failure Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Heart failure Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: EKG disturbance Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Hepatic failure Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Anemia Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Leucopenia Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Vascular disease Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Toxidermia Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Osteoarticular adverse event Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Death Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Acute respiratory distress syndrome Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Description: defined by the Medical Dictionary for Regulatory Activities (MeDRA) terms
Measure: Pulmonary embolism or pulmonary hypertension Time: Case reported in the World Health Organization (WHO) database of individual safety case reports to 17/03/2020Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports